ENDV's free cash flow for Q was $-100.00K. For the fiscal year, ENDV's free cash flow was decreased by $307.75K and operating cash flow was $-100.00K. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	$ -617.83K	$ -678.84K	$ -986.58K	$ -741.59K	$ -2.54M	$ -2.88M
Investing Cash Flow	-	-	-	$ 0.00	$ -2.59K	$ -8.97K
Financing Cash Flow	$ 606.76K	$ 593.00K	$ 1.06M	$ 736.12K	$ 2.18M	$ 3.18M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 43.64K	$ 98.00	$ 85.94K	$ 13.42K	$ 18.89K	$ 379.15K
Income Tax Paid Supplemental Data	-	-	-	$ 0.00	$ 0.00	$ 0.00
Interest Paid Supplemental Data	-	-	-	$ 25.75K	$ 17.00K	$ 248.73K
Issuance Of Capital Stock	$ 398.76K	$ 142.00K	$ 126.00K	$ 150.00K	$ 423.34K	$ 922.50K
Issuance Of Debt	$ 208.00K	$ 451.00K	$ 933.10K	$ 608.12K	$ 2.00M	$ 2.84M
Repayment Of Debt	$ -52.00K	$ -14.00K	$ -16.90K	$ 0.00	$ -130.00K	$ -559.72K
Free Cash Flow	$ -617.83K	$ -678.84K	$ -986.58K	$ -741.59K	$ -2.54M	$ -2.89M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Endonovo Therapeutics Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing